/
ELAB
$1.21+$0.07 (+6.14%)live
Held by
0
portfolios on TandT
Bookmarked by
0
users
Avg position size
—
of holders' portfolios
13F filers
0
institutions
Market cap
$5.2M
5M shares
52-week range
$1.11 – $309.12
0% from low
Sector
PHARMACEUTICAL PREPARATIONS
Exchange
NASDAQ
CS
Price (6 mo)
Loading chart…
Change$-399838.79
Valuation
Financials
Loading chart…
Click rows below (any statement) to add/remove series. Selection stays as you switch tabs.
| 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | |
|---|---|---|---|---|---|---|
| Revenue | $0 | $827 | $766.3K | $1.7M | $2.5M | $590.1K |
| Cost of revenue | $0 | $2.8K | $319.0K | $578.0K | $670.2K | $515.3K |
| Gross profit | $0 | −$2.0K | $447.3K | $1.1M | $1.8M | $74.8K |
| Gross margin | — | -244.0% | 58.4% | 66.2% | 72.8% | 12.7% |
| R&D | $118.9K | $123.6K | $228.7K | $426.2K | $104.7K | $147.0K |
| Operating income | −$221.8K | −$785.1K | −$1.8M | −$1.1M | −$1.9M | −$7.4M |
| EBITDA | −$1.1K | −$782.3K | −$1.8M | −$3.7M | −$3.2M | −$7.3M |
| Net income | −$222.9K | −$784.7K | −$1.8M | −$4.3M | −$6.2M | −$7.7M |
| Net margin | — | -94889.8% | -234.9% | -251.2% | -253.1% | -1306.3% |
| EPS (diluted) | -1.98 | -6.96 | -15.84 | -0.40 | -6592.32 | -378.74 |
Annual figures · source: Financial Modeling Prep
Peer comparison
PMGC Holdings Inc. Common Stock
PMGC Holdings Inc IS advancing in Medical Aesthetics and Biopharmaceutical Innovation. It specializes in Skin Aesthetics, Obesity, and Metabolic Health business.
www.pmgcholdings.com- Employees
- 34
- IPO / List date
- Nov 21, 2023
- HQ
- NEWPORT BEACH, CA
Held by traders on TradeandTell
No one on the platform currently holds ELAB.
Super investors & insiders
Institutions holding (13F)
No tracked institution reports a position in ELAB as of their last filing.
Insider activity (SEC Form 4)
Stock splits
| Execution date | Ratio |
|---|---|
| 2026-03-10 | 1-for-6reverse |
| 2026-01-06 | 1-for-4reverse |
| 2025-09-02 | 1-for-3.5reverse |
| 2025-03-10 | 1-for-7reverse |
| 2024-11-27 | 1-for-200reverse |
Recent trades on TradeandTell
No one on the platform has traded ELAB yet.
